ANGO News and Press, AngioDynamics Inc.

2026-02-27 15:57:23 ET On February 6, 2026, Bastion Asset Management disclosed a new position in Parsons (NYSE:PSN) , acquiring 128,186 shares in the fourth quarter—an estimated $8.04 million trade based on quarterly average pricing. According to a filing with the Secur...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced, that Jim Clemmer, President and Chie...

Growing Clinical Evidence and Physician Adoption Broaden NanoKnife IRE Technology as Treatment Option for Major Solid Tumor Types AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vasc...

The ALPHA-PE Research Fund Supports Independent, Physician-Led Studies to Advance Real-World PE Evidence AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding ca...

Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer...

2026-01-14 20:16:02 ET AngioDynamics, Inc. (ANGO) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 6:00 PM EST... Read the full article on Seeking Alpha For further details see: AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conferenc...

2026-01-06 11:24:14 ET Shares of AngioDynamics (NASDAQ: ANGO) were sinking 13.1% as of 11:02 a.m. ET. The sell-off came after the medical technology company announced its third-quarter results before the market open. Those results were actually quite good. AngioDynamics reported...

2026-01-06 10:18:48 ET More on AngioDynamics AngioDynamics, Inc. (ANGO) Q2 2026 Earnings Call Transcript AngioDynamics, Inc. 2026 Q2 - Results - Earnings Call Presentation AngioDynamics: Growth Remains Under The Radar AngioDynamics Non-GAAP EPS of $0.00 beats...

2026-01-06 10:18:00 ET AngioDynamics, Inc. (ANGO) Q2 2026 Earnings Call January 6, 2026 8:00 AM EST Company Participants James Clemmer - CEO, President & Director Stephen Trowbridge - Executive VP & CFO ... Read the full article on Seeking Alpha F...

2026-01-06 06:30:20 ET More on AngioDynamics AngioDynamics: Growth Remains Under The Radar AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 Transcript AngioDynamics FQ2 2026 Earnings Preview Seeking Alpha’s Quant Rating on A...